The level of beta-2 microglobulin rises in people with multiple myeloma. Doctos use the level of beta-2 microglobulin to predict a patient's prognosis.
Want to keep up with the latest news from Boston Medical Center? Sign up for our monthly patient newsletter, Your BMC.